tm
Seeing Is Believing
tm
Seeing Is Believing
with an average price target of $34.2. This is a potential upside of $6.2 (22.14%) from yesterday's end of day stock price of $28.
Ambrx Biopharma American Depositary Shares's activity chart (see below) currently has 30 price targets and 23 ratings on display.
Analysts average stock forecasts to be materialized ratio is 75% with an average time for these price targets to be met of 101 days.
Most recent stock forecast was given by JOEL BEATTY from BAIRD on 16-Jan-2024. First documented stock forecast 28-Feb-2022.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold
$22
$-6 (-21.43%)
$22
1 years 10 months 21 days ago
(16-Jan-2024)
5/6 (83.33%)
$-5.68 (-20.52%)
113
Hold
$15
1 years 10 months 27 days ago
(10-Jan-2024)
3/3 (100%)
$3.28 (27.99%)
65
Hold
$28
$26
1 years 10 months 28 days ago
(09-Jan-2024)
2/2 (100%)
$0.45 (1.63%)
105
Hold
$9
$-19 (-67.86%)
$10
2 years 22 days ago
(15-Nov-2023)
2/3 (66.67%)
$-0.45 (-4.76%)
181
Buy
$32
$4 (14.29%)
$33
2 years 23 days ago
(14-Nov-2023)
0/3 (0%)
$22.99 (255.16%)
What is AMAM (Ambrx Biopharma American Depositary Shares) average time for price targets to be met?
Which analyst has the current highest performing score on AMAM (Ambrx Biopharma American Depositary Shares) with a proven track record?
Which analyst has the current lower performing score on AMAM (Ambrx Biopharma American Depositary Shares) with a proven track record?
Which analyst has the most public recommendations on AMAM (Ambrx Biopharma American Depositary Shares)?
Which analyst is the currently most bullish on AMAM (Ambrx Biopharma American Depositary Shares)?
Which analyst is the currently most reserved on AMAM (Ambrx Biopharma American Depositary Shares)?
